Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Zannad et al. (Sun,) studied this question.

www.synapsesocial.com/papers/697817f9f226c9e734a25b6f — DOI: https://doi.org/10.1056/nejmoa1009492

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Rationale and Design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)· 2010 · 81 citations
2. Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction· 1999 · 374 citations
3. Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure· 1999 · 881 citations
4. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure· 2000 · 2,936 citations
5. Calculating the number needed to treat for trials where the outcome is time to an event· 1999 · 718 citations